Autres langues Glenmark Pharmaceuticals Limited

Actions

GLENMARK

INE935A01035

Produits pharmaceutiques

Marché Fermé - NSE India S.E. 13:05:08 04/09/2026			Varia. 5j.	Varia. 1 janv.
2 437,20 ^INR	-0,89%		-0,93%	+19,75%

20/08	Glenmark Pharmaceuticals Limited reçoit l'approbation de la FDA américaine pour son spray nasal de propionate de fluticasone à 0,05 mg (50 mcg)/pulvérisation	CI
03/08	Transcript : Glenmark Pharmaceuticals Limited, Q1 2027 Earnings Call, Aug 03, 2026

Autres langues

20/08	Glenmark Pharmaceuticals Limited Receives U.S. FDA Approval For Fluticasone Propionate Nasal Spray 0.05 Mg (50 Mcg)/Spray
31/07	India's Glenmark Pharma posts higher quarterly profit on strong demand
31/07	Glenmark Pharmaceuticals Limited Announces Management Changes, Effective August 1, 2026
31/07	Glenmark Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026
22/07	Shares in Generic-Drug Makers Fall After Trump's Tariff Plan -- Update
22/07	Shares in Generic-Drug Makers Fall After Trump's Tariff Plan
21/07	Glenmark Pharmaceuticals Unit Gets US FDA Nod for Expanded Use of Ryaltris Nasal Spray
07/07	India finds Adani's Mumbai airport shops sold nicotine pouches in breach of law
06/07	Glenmark Pharmaceuticals Launches Olanzapine for Injection
06/07	Glenmark Pharmaceuticals Inc., USA Launches Olanzapine for Injection, 10 Mg/Vial, Single-Dose Vial
17/06	Glenmark Pharmaceuticals Launches Methylene Blue Injection in US
11/06	Glenmark Pharmaceuticals Unit Launches Acne Treatment Winlevi in European Markets
11/06	Cosmo Pharmaceuticals Flags Launch of Acne Treatment in Key Markets Across Europe
05/06	Indian Equities Slip on Friday After RBI Flags Higher Inflation, Lower Growth Outlook
05/06	Glenmark Pharmaceuticals Launches Generic Seizure Drug in US
01/06	Caring Brands Inks Expanded Five-Year Licensing Deal With SanPellegrino Cosmetics
01/06	Glenmark Pharmaceuticals' Profit Soars in Fiscal Q4
29/05	Glenmark Pharmaceuticals Limited Recommends Dividend for the Financial Year 2025-26
29/05	Glenmark Pharma approves transfer of nebulizer brands/ip portfolio to unit
29/05	Glenmark Pharmaceuticals Limited Announces Executive Changes
29/05	Glenmark Pharma Q4 consol net profit 3.01 billion rupees
29/05	Glenmark Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026
18/05	Glenmark Pharmaceuticals Launches Vancomycin Hydrochloride for Injection in US
18/05	Glenmark Pharma launches vancomycin hydrochloride for injection USP, 500 mg/vial and 1 g/vial
05/05	BlinkRx And Glenmark Pharmaceuticals Inc. USA Enable RYALTRIS Nasal Spray Distribution Through BlinkRx Platform